Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
D G R Evans
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Physiology
Concepts & Ideas
Genes & Molecular Sequences
Chemicals & Drugs
Occupations
Sign-in to see full Profile
Network (preview)
30
Lalloo, Fiona
24
Ramsden, Richard
18
Baser, Michael
17
Birch, Jillian
17
Shenton, Andrew
16
Varley, Jennifer
16
Howell, Anthony
12
Wallace, Andrew
11
Maher, Eamonn
11
Eccles, Diana
10
Friedman, Jan
10
Hill, James
9
McGown, Gail
9
Wallace, A
9
Neary, WJ
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of D G R Evans (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Evans D G R; Wallace A
An update on age related mosaic and offspring risk in neurofibromatosis 2 (NF2).
Journal of medical genetics 2009;46(11):792.
-
2009: Evans D G; Gaarenstroom K N; Stirling D; Shenton A; Maehle L; Dørum A; Steel M; Lalloo F; Apold J; Porteous M E; Vasen H F A; van Asperen C J; Moller P
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers.
Journal of medical genetics 2009;46(9):593-7.
-
2009: Evans D G R; Baildam A D; Anderson E; Brain A; Shenton A; Vasen H F A; Eccles D; Lucassen A; Pichert G; Hamed H; Moller P; Maehle L; Morrison P J; Stoppat-Lyonnet D; Gregory H; Smyth E; Niederacher D; Nestle-Krämling C; Campbell J; Hopwood P; Lalloo F; Howell A
Risk reducing mastectomy: outcomes in 10 European centres.
Journal of medical genetics 2009;46(4):254-8.
-
2009: Barrow E; Robinson L; Alduaij W; Shenton A; Clancy T; Lalloo F; Hill J; Evans D G
Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.
Clinical genetics 2009;75(2):141-9.
-
2009: Evans D G R; Binchy A; Shenton A; Hopwood P; Craufurd D
Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives.
Clinical genetics 2009;75(2):124-32.
-
2008: Barrow E; Alduaij W; Robinson L; Shenton A; Clancy T; Lalloo F; Hill J; Evans D G
Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.
Clinical genetics 2008;74(3):233-42.
-
2008: Dallosso A R; Dolwani S; Jones N; Jones S; Colley J; Maynard J; Idziaszczyk S; Humphreys V; Arnold J; Donaldson A; Eccles D; Ellis A; Evans D G; Frayling I M; Hes F J; Houlston R S; Maher E R; Nielsen M; Parry S; Tyler E; Moskvina V; Cheadle J P; Sampson J R
Inherited predisposition to colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3.
Gut 2008;57(9):1252-5.
-
2008: Barrow E; McMahon R; Evans D G; Levine E; Hill J
Cost analysis of biomarker testing for mismatch repair deficiency in node-positive colorectal cancer.
The British journal of surgery 2008;95(7):868-75.
-
2008: Antoniou A C; Hardy R; Walker L; Evans D G; Shenton A; Eeles R; Shanley S; Pichert G; Izatt L; Rose S; Douglas F; Eccles D; Morrison P J; Scott J; Zimmern R L; Easton D F; Pharoah P D P
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.
Journal of medical genetics 2008;45(7):425-31.
-
2008: Hadfield K D; Newman W G; Bowers N L; Wallace A; Bolger C; Colley A; McCann E; Trump D; Prescott T; Evans D G R
Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.
Journal of medical genetics 2008;45(6):332-9.
-
2008: Evans D G R; Young K; Bulman M; Shenton A; Wallace A; Lalloo F
Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families.
Clinical genetics 2008;73(4):338-45.
-
2008: Evans D Gareth R; Ramsden Richard T; Shenton Andrew; Gokhale Carolyn; Bowers Naomi; Huson Susan M; Wallace Andrew J
What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?
Journal of neurosurgery 2008;108(1):92-6.
-
2008: Upadhyaya M; Kluwe Lan; Spurlock G; Monem Bisma; Majounie E; Mantripragada K; Ruggieri Martino; Chuzhanova N; Evans D G; Ferner R; Thomas N; Guha A; Mautner V
Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs).
Human mutation 2008;29(1):74-82.
-
2008: Evans D G R; Bulman Mike; Young Karen; Howard Emma; Bayliss Stuart; Wallace Andrew; Lalloo Fiona
BRCA1/2 mutation analysis in male breast cancer families from North West England.
Familial cancer 2008;7(2):113-7.
-
2007: Evans D Gareth; Walsh Sheila; Hill James; McMahon Raymond T
Strategies for identifying hereditary nonpolyposis colon cancer.
Seminars in oncology 2007;34(5):411-7.
-
2007: Mak T; Senevrayar K; Lalloo F; Evans D G R; Hill J
The impact of new screening protocol on individuals at increased risk of colorectal cancer.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2007;9(7):635-40.
-
2007: Moller Pal; Evans D Gareth; Reis Marta M; Gregory Helen; Anderson Elaine; Maehle Lovise; Lalloo Fiona; Howell Anthony; Apold Jaran; Clark Neal; Lucassen Anneke; Steel C Michael
Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status.
International journal of cancer. Journal international du cancer 2007;121(5):1017-20.
-
2007: Speake D; Evans D G; Lalloo F; Scott N A; Hill J
Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations.
The British journal of surgery 2007;94(8):1009-13.
-
2007: Sharif S; Moran A; Huson S M; Iddenden R; Shenton A; Howard E; Evans D G R
Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening.
Journal of medical genetics 2007;44(8):481-4.
-
2007: Evans D Gareth R; Ramsden R T; Shenton A; Gokhale C; Bowers N L; Huson S M; Pichert G; Wallace A
Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification.
Journal of medical genetics 2007;44(7):424-8.
-
2007: Evans D G R; Ramsden R T; Gokhale C; Bowers N; Huson S M; Wallace A
Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?
Clinical genetics 2007;71(4):354-8.
-
2007: Draffan E A; Evans D G; Blenkhorn P
Use of assistive technology by students with dyslexia in post-secondary education.
Disability and rehabilitation. Assistive technology 2007;2(2):105-16.
-
2007: Foster C; Watson M; Eeles R; Eccles D; Ashley S; Davidson R; Mackay J; Morrison P J; Hopwood P; Evans D G R;
Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up.
British journal of cancer 2007;96(5):718-24.
-
2007: Ferner Rosalie E; Huson Susan M; Thomas Nick; Moss Celia; Willshaw Harry; Evans D Gareth; Upadhyaya Meena; Towers Richard; Gleeson Michael; Steiger Christine; Kirby Amanda
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.
Journal of medical genetics 2007;44(2):81-8.
-
2007: Upadhyaya M; Huson S M; Davies M; Thomas N; Chuzhanova N; Giovannini S; Evans D G; Howard E; Kerr B; Griffiths S; Consoli C; Side L; Adams D; Pierpont M; Hachen R; Barnicoat A; Li H; Wallace P; Van Biervliet J P; Stevenson D; Viskochil D; Baralle D; Haan E; Riccardi V; Turnpenny P; Lazaro C; Messiaen L
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation.
American journal of human genetics 2007;80(1):140-51.
-
2007: Smith A; Moran A; Boyd M C; Bulman M; Shenton A; Smith L; Iddenden R; Woodward E R; Lalloo F; Maher E R; Evans D G R
Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening.
Journal of medical genetics 2007;44(1):10-15.
-
2007: Evans D Gareth R; Howell Anthony
Breast cancer risk-assessment models.
Breast cancer research : BCR 2007;9(5):213.
-
2007: Mak Tony; Speake Douglas; Lalloo Fiona; Hill James; Evans D G R
Familial colorectal cancer referral to regional genetics department--a single centre experience.
Familial cancer 2007;6(1):81-7.
-
2006: Blenkhorn Paul; Evans David Gareth
A screen magnifier using "high level" implementation techniques.
IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 2006;14(4):501-4.
-
2006: Naseem H; Boylan J; Speake D; Leask K; Shenton A; Lalloo F; Hill J; Trump D; Evans D G R
Inherited association of breast and colorectal cancer: limited role of CHEK2 compared with high-penetrance genes.
Clinical genetics 2006;70(5):388-95.
-
2006: Griebsch I; Brown J; Boggis C; Dixon A; Dixon M; Easton D; Eeles R; Evans D G; Gilbert F J; Hawnaur J; Kessar P; Lakhani S R; Moss S M; Nerurkar A; Padhani A R; Pointon L J; Potterton J; Thompson D; Turnbull L W; Walker L G; Warren R; Leach M O;
Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.
British journal of cancer 2006;95(7):801-10.
-
2006: Maurice Andrew; Howell Anthony; Evans D Gareth; O'Neil Alison C; Scobie Sue
Predicting compliance in a breast cancer prevention trial.
The breast journal 2006;12(5):446-50.
-
2006: Evans D Gareth R; Lalloo Fiona; Eccles Diana
Optimal selection of individuals for BRCA mutation testing.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(20):3311; author reply 3311-2.
-
2006: Maurice A; Evans D G R; Shenton A; Ashcroft L; Baildam A; Barr L; Byrne G; Bundred N; Boggis C; Wilson M; Duffy S W; Howell A
Screening younger women with a family history of breast cancer--does early detection improve outcome?
European journal of cancer (Oxford, England : 1990) 2006;42(10):1385-90.
-
2006: Sharif Saba; Ferner Rosalie; Birch Jillian M; Gillespie James E; Gattamaneni H Rao; Baser Michael E; Evans D Gareth R
Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2570-5.
-
2006: Lalloo Fiona; Varley Jennifer; Moran Anthony; Ellis David; O'dair Lindsay; Pharoah Paul; Antoniou Antonis; Hartley Roger; Shenton Andrew; Seal Sheila; Bulman Barbara; Howell Anthony; Evans D Gareth R
BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.
European journal of cancer (Oxford, England : 1990) 2006;42(8):1143-50.
-
2006: Bramley M; Clarke R B; Howell A; Evans D G R; Armer T; Baildam A D; Anderson E
Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations.
British journal of cancer 2006;94(7):1021-8.
-
2006: Evans D G R; Birch J M; Ramsden R T; Sharif S; Baser M E
Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.
Journal of medical genetics 2006;43(4):289-94.
-
2006: Baser Michael E; Friedman J M; Evans D Gareth R
Increasing the specificity of diagnostic criteria for schwannomatosis.
Neurology 2006;66(5):730-2.
-
2006: Stirling Diane; Porteous Mary E; Evans D Gareth; Pichert Gabriella; Steel Michael
Familial ovarian cancer screening.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(6):e11.
-
2006: Mitchell Gillian; Antoniou Antonis C; Warren Ruth; Peock Susan; Brown Judith; Davies Russell; Mattison Jenny; Cook Margaret; Warsi Iqbal; Evans D Gareth; Eccles Diana; Douglas Fiona; Paterson Joan; Hodgson Shirley; Izatt Louise; Cole Trevor; Burgess Lucy; Eeles Ros; Easton Douglas F
Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Cancer research 2006;66(3):1866-72.
-
2006: Murray A J; Hughes T A T; Neal J W; Howard E; Evans D G R; Harper P S
A case of multiple cutaneous schwannomas; schwannomatosis or neurofibromatosis type 2?
Journal of neurology, neurosurgery, and psychiatry 2006;77(2):269-71.
-
2006: Johnson Marianne J; Evans D Gareth; Mohamed Zeinab; Caress Ann-Louise
The development and evaluation of alternative communication strategies to facilitate interactions with Somali refugees in primary care: a preliminary study.
Informatics in primary care 2006;14(3):183-9.
-
2006: Antoniou Antonis C; Shenton Andrew; Maher Eamonn R; Watson Emma; Woodward Emma; Lalloo Fiona; Easton Douglas F; Evans D Gareth
Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers.
Breast cancer research : BCR 2006;8(6):R72.
-
2005: Howell Anthony; Sims Andrew H; Ong Kai Ren; Harvie Michelle N; Evans D Gareth R; Clarke Robert B
Mechanisms of Disease: prediction and prevention of breast cancer--cellular and molecular interactions.
Nature clinical practice. Oncology 2005;2(12):635-46.
-
2005: Buckley Patrick G; Mantripragada Kiran K; Díaz de Ståhl Teresita; Piotrowski Arkadiusz; Hansson Caisa M; Kiss Hajnalka; Vetrie David; Ernberg Ingemar T; Nordenskjöld Magnus; Bolund Lars; Sainio Markku; Rouleau Guy A; Niimura Michihito; Wallace Andrew J; Evans D Gareth R; Grigelionis Gintautas; Menzel Uwe; Dumanski Jan P
Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.
Human mutation 2005;26(6):540-9.
-
2005: Evans D G R; Lalloo F; Hopwood P; Maurice A; Baildam A; Brain A; Barr L; Howell A
Surgical decisions made by 158 women with hereditary breast cancer aged <50 years.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2005;31(10):1112-8.
-
2005: Baser M E; Mautner V-F; Parry D M; Evans D G R
Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2.
Journal of medical genetics 2005;42(12):903-6.
-
2005: Díaz de Ståhl Teresita; Hansson Caisa M; de Bustos Cecilia; Mantripragada Kiran K; Piotrowski Arkadiusz; Benetkiewicz Magdalena; Jarbo Caroline; Wiklund Leif; Mathiesen Tiit; Nyberg Gunnar; Collins V Peter; Evans D Gareth; Ichimura Koichi; Dumanski Jan P
High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas.
Human genetics 2005;118(1):35-44.
-
2005: Stirling Diane; Evans D Gareth R; Pichert Gabriella; Shenton Andrew; Kirk Elaine N; Rimmer Sylvia; Steel C Michael; Lawson Sheila; Busby-Earle R M Camille; Walker Jane; Lalloo Fiona I; Eccles Diana M; Lucassen Anneke M; Porteous Mary E
Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5588-96.
-
2005: Evans D G R; Maher E R; Baser M E
Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms.
Journal of medical genetics 2005;42(8):630-2.
-
2005: Baser M E; Kuramoto L; Woods R; Joe H; Friedman J M; Wallace A J; Ramsden R T; Olschwang S; Bijlsma E; Kalamarides M; Papi L; Kato R; Carroll J; Lázaro C; Joncourt F; Parry D M; Rouleau G A; Evans D G R
The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.
Journal of medical genetics 2005;42(7):540-6.
-
2005: Evans D G R; Lalloo F; Wallace A; Rahman N
Update on the Manchester Scoring System for BRCA1 and BRCA2 testing.
Journal of medical genetics 2005;42(7):e39.
-
2005: Robinson James P; Johnson Victoria L; Rogers Pauline A; Houlston Richard S; Maher Earmonn R; Bishop D Timothy; Evans D Gareth R; Thomas Huw J W; Tomlinson Ian P M; Silver Andrew R J
Evidence for an association between compound heterozygosity for germ line mutations in the hemochromatosis (HFE) gene and increased risk of colorectal cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1460-3.
-
2005: Leach M O; Boggis C R M; Dixon A K; Easton D F; Eeles R A; Evans D G R; Gilbert F J; Griebsch I; Hoff R J C; Kessar P; Lakhani S R; Moss S M; Nerurkar A; Padhani A R; Pointon L J; Thompson D; Warren R M L;
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
Lancet 2005;365(9473):1769-78.
-
2005: Evans D G R; Baser M E; O'Reilly B; Rowe J; Gleeson M; Saeed S; King A; Huson S M; Kerr R; Thomas N; Irving R; MacFarlane R; Ferner R; McLeod R; Moffat D; Ramsden R
Management of the patient and family with neurofibromatosis 2: a consensus conference statement.
British journal of neurosurgery 2005;19(1):5-12.
-
2005: Evans D G; Shenton A; Sharif S; Woodward E; Lalloo F; Maher E R
Non-random transmission of mutant alleles to female offspring in BRCA carriers.
Journal of medical genetics 2005;42(2):e6.
-
2005: Evans D Gareth R; Moran Anthony; King Andrew; Saeed S; Gurusinghe Nihal; Ramsden Richard
Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2005;26(1):93-7.
-
2005: Herwadker Amit; Vokurka Elizabeth A; Evans D Gareth R; Ramsden Richard T; Jackson Alan
Size and growth rate of sporadic vestibular schwannoma: predictive value of information available at presentation.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2005;26(1):86-92.
-
2005: Evans D G R; Watson C; King A; Wallace A J; Baser M E
Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
Journal of medical genetics 2005;42(1):45-8.
-
2005: Baser M E; Rai H; Wallace A J; Evans D G R
Neurofibromatosis 2 (NF2) and malignant mesothelioma in a man with a constitutional NF2 missense mutation.
Familial cancer 2005;4(4):321-2.
-
2004: Watson M; Foster C; Eeles R; Eccles D; Ashley S; Davidson R; Mackay J; Morrison P J; Hopwood P; Evans D G R;
Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.
British journal of cancer 2004;91(10):1787-94.
-
2004: Evans D Gareth; Blenkhorn Paul
Producing preferred format material from Microsoft Word.
IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 2004;12(3):325-30.
-
2004: Baser Michael E; Kuramoto Lisa; Joe Harry; Friedman J M; Wallace Andrew J; Gillespie James E; Ramsden Richard T; Evans D Gareth R
Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study.
American journal of human genetics 2004;75(2):231-9.
-
2004: Tsilchorozidou T; Menko F H; Lalloo F; Kidd A; De Silva R; Thomas H; Smith P; Malcolmson A; Dore J; Madan K; Brown A; Yovos J G; Tsaligopoulos M; Vogiatzis N; Baser M E; Wallace A J; Evans D G R
Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2.
Journal of medical genetics 2004;41(7):529-34.
-
2004: Mak T; Lalloo F; Evans D G R; Hill J
Molecular stool screening for colorectal cancer.
The British journal of surgery 2004;91(7):790-800.
-
2004: Evans D G R; Eccles D M; Rahman N; Young K; Bulman M; Amir E; Shenton A; Howell A; Lalloo F
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.
Journal of medical genetics 2004;41(6):474-80.
-
2004: Evans D G R; Neuhausen S L; Bulman M; Young K; Gokhale D; Lalloo F
Haplotype and cancer risk analysis of two common mutations, BRCA1 4184del4 and BRCA2 2157delG, in high risk northwest England breast/ovarian families.
Journal of medical genetics 2004;41(2):e21.
-
2004: Wallace A J; Watson C J; Oward E; Evans D G R; Elles R G
Mutation scanning of the NF2 gene: an improved service based on meta-PCR/sequencing, dosage analysis, and loss of heterozygosity analysis.
Genetic testing 2004;8(4):368-80.
-
2004: Foster C; Evans D G R; Eeles R; Eccles D; Ashley S; Brooks L; Cole T; Cook J; Davidson R; Gregory H; Mackay J; Morrison P J; Watson M
Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.
Genetic testing 2004;8(1):23-9.
-
2004: Evans D Gareth; Howell Anthony
Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?
Breast cancer research : BCR 2004;6(1):E7.
-
2003: Astuti Dewi; Hart-Holden Niki; Latif Farida; Lalloo Fiona; Black Graeme C; Lim Caron; Moran Anthony; Grossman Ashley B; Hodgson Shirley V; Freemont Anthony; Ramsden Richard; Eng Charis; Evans D Gareth R; Maher Eamonn R
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Clinical endocrinology 2003;59(6):728-33.
-
2003: Black Graeme C M; Mazerolle Chantal J; Wang Yaping; Campsall Katrina D; Petrin Dino; Leonard Brian C; Damji Karim F; Evans D Gareth; McLeod David; Wallace Valerie A
Abnormalities of the vitreoretinal interface caused by dysregulated Hedgehog signaling during retinal development.
Human molecular genetics 2003;12(24):3269-76.
-
2003: Amir E; Evans D G; Shenton A; Lalloo F; Moran A; Boggis C; Wilson M; Howell A
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.
Journal of medical genetics 2003;40(11):807-14.
-
2003: Warren C; James L A; Ramsden R T; Wallace A; Baser M E; Varley J M; Evans D G
Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.
Journal of medical genetics 2003;40(11):802-6.
-
2003: Baser M E; Kuramoto L; Joe H; Friedman J M; Wallace A J; Ramsden R T; Evans D G R
Genotype-phenotype correlations for cataracts in neurofibromatosis 2.
Journal of medical genetics 2003;40(10):758-60.
-
2003: Evans D Gareth; Diggle Tim; Kurniawan Sri H; Blenkhorn Paul
An investigation into formatting and layout errors produced by blind word-processor users and an evaluation of prototype error prevention and correction techniques.
IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 2003;11(3):257-68.
-
2003: Evans D G R; Bulman M; Young K; Gokhale D; Lalloo F
Sensitivity of BRCA1/2 mutation testing in 466 breast/ovarian cancer families.
Journal of medical genetics 2003;40(9):e107.
-
2003: Sampson Julian R; Dolwani Sunil; Jones Sian; Eccles Diana; Ellis Anthony; Evans D Gareth; Frayling Ian; Jordan Sheila; Maher Eamonn R; Mak Tony; Maynard Julie; Pigatto Francesca; Shaw Joan; Cheadle Jeremy P
Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH.
Lancet 2003;362(9377):39-41.
-
2003: Moyhuddin A; Baser M E; Watson C; Purcell S; Ramsden R T; Heiberg A; Wallace A J; Evans D G R
Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring.
Journal of medical genetics 2003;40(6):459-63.
-
2003: Woods Ryan; Friedman J M; Evans D Gareth R; Baser Michael E; Joe Harry
Exploring the "two-hit hypothesis" in NF2: tests of two-hit and three-hit models of vestibular schwannoma development.
Genetic epidemiology 2003;24(4):265-72.
-
2003: Mohyuddin A; Vokurka E A; Evans D G R; Ramsden R T; Jackson A
Is clinical growth index a reliable predictor of tumour growth in vestibular schwannomas?
Clinical otolaryngology and allied sciences 2003;28(2):85-90.
-
2003: Lalloo Fiona; Varley Jennifer; Ellis David; Moran Anthony; O'Dair Lindsay; Pharoah Paul; Evans D Gareth R;
Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.
Lancet 2003;361(9363):1101-2.
-
2003: Szudek Jacek; Evans D Gareth; Friedman Jan M
Patterns of associations of clinical features in neurofibromatosis 1 (NF1).
Human genetics 2003;112(3):289-97.
-
2003: Hopwood P; van Asperen C J; Borreani G; Bourret P; Decruyenaere M; Dishon S; Eisinger F; Evans D G R; Evers-Kiebooms G; Gangeri L; Hagoel L; Legius E; Nippert I; Rennert G; Schlegelberger B; Sevilla C; Sobol H; Tibben A; Welkenhuysen M; Julian-Reynier C
Cancer genetics service provision: a comparison of seven European centres.
Community genetics 2003;6(4):192-205.
-
2002: Blenkhorn Paul; Evans David Gareth; Baude Alex
Full-screen magnification for windows using DirectX Overlays.
IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 2002;10(4):225-31.
-
2002: Baser M E; Friedman J M; Wallace A J; Ramsden R T; Joe H; Evans D G R
Evaluation of clinical diagnostic criteria for neurofibromatosis 2.
Neurology 2002;59(11):1759-65.
-
2002: Evans D G R; Birch J M; Thorneycroft M; McGown G; Lalloo F; Varley J M
Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome.
Journal of medical genetics 2002;39(12):941-4.
-
2002: Evans D G R; Lalloo F
Risk assessment and management of high risk familial breast cancer.
Journal of medical genetics 2002;39(12):865-71.
-
2002: Zhao Y; Kumar R A; Baser M E; Evans D G R; Wallace A; Kluwe L; Mautner V F; Parry D M; Rouleau G A; Joe H; Friedman J M
Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2).
Genetic epidemiology 2002;23(3):245-59.
-
2002: Møller Pål; Borg Ake; Evans D Gareth; Haites Neva; Reis Marta M; Vasen Hans; Anderson Elaine; Steel C Michael; Apold Jaran; Goudie David; Howell Anthony; Lalloo Fiona; Maehle Lovise; Gregory Helen; Heimdal Ketil
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy.
International journal of cancer. Journal international du cancer 2002;101(6):555-9.
-
2002: Baser Michael E; Friedman J M; Aeschliman Dana; Joe Harry; Wallace Andrew J; Ramsden Richard T; Evans D Gareth R
Predictors of the risk of mortality in neurofibromatosis 2.
American journal of human genetics 2002;71(4):715-23.
-
2002: Evans David Gareth; Pettitt Stephen; Blenkhorn Paul
A modified Perkins Brailler for text entry into windows applications.
IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 2002;10(3):204-6.
-
2002: McAllister M; O'Malley K; Hopwood P; Kerr B; Howell A; Evans D G R
Management of women with a family history of breast cancer in the North West Region of England: training for implementing a vision of the future.
Journal of medical genetics 2002;39(7):531-5.
-
2002: Singhal S; Birch J M; Kerr B; Lashford L; Evans D G R
Neurofibromatosis type 1 and sporadic optic gliomas.
Archives of disease in childhood 2002;87(1):65-70.
-
2002: Mohyuddin A; Neary W J; Wallace A; Wu C L; Purcell S; Reid H; Ramsden R T; Read A; Black G; Evans D G R
Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
Journal of medical genetics 2002;39(5):315-22.
-
2002: Evans D G R; Baser M E; McGaughran J; Sharif S; Howard E; Moran A
Malignant peripheral nerve sheath tumours in neurofibromatosis 1.
Journal of medical genetics 2002;39(5):311-4.
-
2002: Foster C; Evans D G R; Eeles R; Eccles D; Ashley S; Brooks L; Davidson R; Mackay J; Morrison P J; Watson M
Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort.
British journal of cancer 2002;86(8):1209-16.
-
2002: Porter Timothy R; Richards Frances M; Houlston Richard S; Evans D Gareth R; Jankowski Janusz A; Macdonald Fiona; Norbury Gail; Payne Stewart J; Fisher Samantha A; Tomlinson Ian; Maher Eamonn R
Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
Oncogene 2002;21(12):1928-33.
-
2002: Bennett K E; Howell A; Evans D G R; Birch J M
A follow-up study of breast and other cancers in families of an unselected series of breast cancer patients.
British journal of cancer 2002;86(5):718-22.
-
2002: Evans D Gareth; Howell Anthony; Baildam Andrew; Brain Ann; Lalloo Fiona; Hopwood Penelope
Re: risk-reduction mastectomy: clinical issues and research needs.
Journal of the National Cancer Institute 2002;94(4):307-8.
-
2001: Hill J; Walsh S; Evans D G
Screening of patients at high risk of colorectal cancer.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2001;3(5):308-11.
-
2001: Birch J M; Alston R D; McNally R J; Evans D G; Kelsey A M; Harris M; Eden O B; Varley J M
Relative frequency and morphology of cancers in carriers of germline TP53 mutations.
Oncogene 2001;20(34):4621-8.
-
2001: Baria K; Warren C; Roberts S A; West C M; Evans D G; Varley J M; Scott D
Correspondence re: A. Rothfuss et al., Induced micronucleus frequencies in peripheral blood lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res., 60: 390-394, 2000.
Cancer research 2001;61(15):5948-9.
-
2001: Barr L; Evans D G
There may never be a final cure for breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2001;27(4):338-9.
-
2001: Astuti D; Douglas F; Lennard T W; Aligianis I A; Woodward E R; Evans D G; Eng C; Latif F; Maher E R
Germline SDHD mutation in familial phaeochromocytoma.
Lancet 2001;357(9263):1181-2.
-
2001: Hopwood P; Shenton A; Lalloo F; Evans D G; Howell A
Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer.
Journal of medical genetics 2001;38(2):139.
-
2001: Verma L; Porter T R; Richards F M; Rajpar M H; Evans D G; Macdonald F; Maher E R
Germline mutation analysis of the transforming growth factor beta receptor type II (TGFBR2) and E-cadherin (CDH1) genes in early onset and familial colorectal cancer.
Journal of medical genetics 2001;38(2):E7.
-
2001: Evans D G; Bulman M; Young K; Gokhale D; Lalloo F
High detection rate for BRCA2 mutations in male breast cancer families from North West England.
Familial cancer 2001;1(3-4):131-3.
-
2000: Evans D G; Newton V; Neary W; Baser M E; Wallace A; Macleod R; Jenkins J P; Gillespie J; Ramsden R T
Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2).
Journal of medical genetics 2000;37(12):944-7.
-
2000: Szudek J; Birch P; Riccardi V M; Evans D G; Friedman J M
Associations of clinical features in neurofibromatosis 1 (NF1).
Genetic epidemiology 2000;19(4):429-39.
-
2000: Evans D G; Sainio M; Baser M E
Neurofibromatosis type 2.
Journal of medical genetics 2000;37(12):897-904.
-
2000: Lalloo F; Baildam A; Brain A; Hopwood P; Evans D G; Howell A
A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2000;26(7):711-3.
-
2000: Baser M E; Wallace A J; Strachan T; Evans D G
Clinical and molecular correlates of somatic mosaicism in neurofibromatosis 2.
Journal of medical genetics 2000;37(7):542-3.
-
2000: Lim D J; Rubenstein A E; Evans D G; Jacks T; Seizinger B G; Baser M E; Beebe D; Brackmann D E; Chiocca E A; Fehon R G; Giovannini M; Glazer R; Gusella J F; Gutmann D H; Korf B; Lieberman F; Martuza R; McClatchey A I; Parry D M; Pulst S M; Ramesh V; Ramsey W J; Ratner N; Rutkowski J L; Ruttledge M; Weinstein D E
Advances in neurofibromatosis 2 (NF2): a workshop report.
Journal of neurogenetics 2000;14(2):63-106.
-
2000: Brown J; Coulthard A; Dixon A K; Dixon J M; Easton D F; Eeles R A; Evans D G; Gilbert F G; Hayes C; Jenkins J P; Leach M O; Moss S M; Padhani A P; Pointon L J; Ponder B A; Sloane J P; Turnbull L W; Walker L G; Warren R M; Watson W;
Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer.
Breast (Edinburgh, Scotland) 2000;9(2):78-82.
-
2000: Brown J; Coulthard A; Dixon A K; Dixon J M; Easton D F; Eeles R A; Evans D G; Gilbert F G; Hayes C; Jenkins J P; Leach M O; Moss S M; Padhani A P; Pointon L J; Ponder B A; Sloane J P; Turnbull L W; Walker L G; Warren R M; Watson W;
Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer.
Breast (Edinburgh, Scotland) 2000;9(2):72-7.
-
2000: Evans D G; Drew R; Blenkhorn P
Controlling mouse pointer position using an infrared head-operated joystick.
IEEE transactions on rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 2000;8(1):107-17.
-
2000: Baser M E; Evans D G; Jackler R K; Sujansky E; Rubenstein A
Neurofibromatosis 2, radiosurgery and malignant nervous system tumours.
British journal of cancer 2000;82(4):998.
-
1999: Morrison P J; Steel C M; Vasen H F; Eccles D; Evans D G; Møller P; Hodgson S; Stoppa-Lyonnet D; Chang-Claude J; Caligo M; Olah E; Haites N E; Nevin N C
Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe.
Disease markers 1999;15(1-3):159-65.
-
1999: Evans D G; Anderson E; Lalloo F; Vasen H; Beckmann M; Eccles D; Hodgson S; Møller P; Chang-Claude J; Morrison P; Stoppa-Lyonnet D; Steel M; Haites N
Utilisation of prophylactic mastectomy in 10 European centres.
Disease markers 1999;15(1-3):148-51.
-
1999: Stoppa-Lyonnet D; Caligo M; Eccles D; Evans D G; Haites N E; Hodgson N S; Møller P; Morrison P J; Steel C M; Vasen H F; Chang-Claude J
Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?
Disease markers 1999;15(1-3):67-8.
-
1999: Varley J M; McGown G; Thorncroft M; James L A; Margison G P; Forster G; Evans D G; Harris M; Kelsey A M; Birch J M
Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.
American journal of human genetics 1999;65(4):995-1006.
-
1999: Verma L; Kane M F; Brassett C; Schmeits J; Evans D G; Kolodner R D; Maher E R
Mononucleotide microsatellite instability and germline MSH6 mutation analysis in early onset colorectal cancer.
Journal of medical genetics 1999;36(9):678-82.
-
1999: Roberts S A; Spreadborough A R; Bulman B; Barber J B; Evans D G; Scott D
Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer?
American journal of human genetics 1999;65(3):784-94.
-
1999: Evans D G; Lye R; Neary W; Black G; Strachan T; Wallace A; Ramsden R T
Probability of bilateral disease in people presenting with a unilateral vestibular schwannoma.
Journal of neurology, neurosurgery, and psychiatry 1999;66(6):764-7.
-
1999: Douglas F S; O'Dair L C; Robinson M; Evans D G; Lynch S A
The accuracy of diagnoses as reported in families with cancer: a retrospective study.
Journal of medical genetics 1999;36(4):309-12.
-
1999: Richards F M; McKee S A; Rajpar M H; Cole T R; Evans D G; Jankowski J A; McKeown C; Sanders D S; Maher E R
Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.
Human molecular genetics 1999;8(4):607-10.
-
1999: McGaughran J M; Harris D I; Donnai D; Teare D; MacLeod R; Westerbeek R; Kingston H; Super M; Harris R; Evans D G
A clinical study of type 1 neurofibromatosis in north west England.
Journal of medical genetics 1999;36(3):197-203.
-
1998: Evans D G
Genetics of cancer: current knowledge and future possibilities.
Hospital medicine (London, England : 1998) 1998;59(12):920-3.
-
1998: Wu C L; Thakker N; Neary W; Black G; Lye R; Ramsden R T; Read A P; Evans D G
Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas.
Journal of medical genetics 1998;35(12):973-7.
-
1998: Vasen H F; Haites N E; Evans D G; Steel C M; Møller P; Hodgson S; Eccles D; Morrison P; Stoppa Lyonet D; Chang-Claude J; Caligo M
Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group.
European journal of cancer (Oxford, England : 1990) 1998;34(12):1922-6.
-
1998: Varley J M; McGown G; Thorncroft M; White G R; Tricker K J; Kelsey A M; Birch J M; Evans D G
A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier.
British journal of cancer 1998;78(8):1081-3.
-
1998: Birch J M; Blair V; Kelsey A M; Evans D G; Harris M; Tricker K J; Varley J M
Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
Oncogene 1998;17(9):1061-8.
-
1998: McAllister M F; Evans D G; Ormiston W; Daly P
Men in breast cancer families: a preliminary qualitative study of awareness and experience.
Journal of medical genetics 1998;35(9):739-44.
-
1998: Evans D G; Wallace A J; Wu C L; Trueman L; Ramsden R T; Strachan T
Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis.
American journal of human genetics 1998;63(3):727-36.
-
1998: Kerr B; Foulkes W D; Cade D; Hadfield L; Hopwood P; Serruya C; Hoare E; Narod S A; Evans D G
False family history of breast cancer in the family cancer clinic.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1998;24(4):275-9.
-
1998: Varley J M; Chapman P; McGown G; Thorncroft M; White G R; Greaves M J; Scott D; Spreadborough A; Tricker K J; Birch J M; Evans D G; Reddel R; Camplejohn R S; Burn J; Boyle J M
Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family.
Oncogene 1998;16(25):3291-8.
-
1998: Evans D G; Trueman L; Wallace A; Collins S; Strachan T
Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.
Journal of medical genetics 1998;35(6):450-5.
-
1998: Lalloo F; Boggis C R; Evans D G; Shenton A; Threlfall A G; Howell A
Screening by mammography, women with a family history of breast cancer.
European journal of cancer (Oxford, England : 1990) 1998;34(6):937-40.
-
1998: Frayling I M; Armstrong J G; Davies D R; Evans D G; Guy S P
Appearances can be deceptive: an APC 1893del4 mutation with unusual properities. Mutations in brief no. 171. Online.
Human mutation 1998;12(3):212.
-
1997: Bijlsma E K; Wallace A J; Evans D G
Misleading linkage results in an NF2 presymptomatic test owing to mosaicism.
Journal of medical genetics 1997;34(11):934-6.
-
1997: Evans D G; Maher E R; Macleod R; Davies D R; Craufurd D
Uptake of genetic testing for cancer predisposition.
Journal of medical genetics 1997;34(9):746-8.
-
1997: Evans D G; Walsh S; Jeacock J; Robinson C; Hadfield L; Davies D R; Kingston R
Incidence of hereditary non-polyposis colorectal cancer in a population-based study of 1137 consecutive cases of colorectal cancer.
The British journal of surgery 1997;84(9):1281-5.
-
1997: Blenkhorn P; Evans D G
A system for enabling blind people to identify landmarks: the sound buoy.
IEEE transactions on rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 1997;5(3):276-8.
-
1997: Varley J M; McGown G; Thorncroft M; Santibanez-Koref M F; Kelsey A M; Tricker K J; Evans D G; Birch J M
Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
Cancer research 1997;57(15):3245-52.
-
1997: Hoban P R; Cowen R L; Mitchell E L; Evans D G; Kelly M; Howard P J; Heighway J
Physical localisation of the breakpoints of a constitutional translocation t(5;6)(q21;q21) in a child with bilateral Wilms' tumour.
Journal of medical genetics 1997;34(4):343-5.
-
1997: Evans D G; Mason S; Huson S M; Ponder M; Harding A E; Strachan T
Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study.
Journal of neurology, neurosurgery, and psychiatry 1997;62(4):361-6.
-
1997: Varley J M; Thorncroft M; McGown G; Appleby J; Kelsey A M; Tricker K J; Evans D G; Birch J M
A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene.
Oncogene 1997;14(7):865-71.
-
1997: Armstrong J G; Davies D R; Guy S P; Frayling I M; Evans D G
APC mutations in familial adenomatous polyposis families in the Northwest of England.
Human mutation 1997;10(5):376-80.
-
1997: Varley J M; Evans D G; Birch J M
Li-Fraumeni syndrome--a molecular and clinical review.
British journal of cancer 1997;76(1):1-14.
-
1996: Thakker N S; Evans D G; Horner K; Davies D R; Armstrong J; Guy S; Harris R; Sloan P
Florid oral manifestations in an atypical familial adenomatous polyposis family with late presentation of colorectal polyps.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1996;25(8):459-62.
-
1996: Varley J M; Thorncroft M; McGown G; Tricker K; Birch J M; Evans D G
A novel deletion within exon 6 of TP53 in a family with Li-Fraumeni-like syndrome, and LOH in a benign lesion from a mutation carrier.
Cancer genetics and cytogenetics 1996;90(1):14-6.
-
1996: Neary W J; Newton V E; Laoide-Kemp S N; Ramsden R T; Griffith G; Evans D G; Harris R; Strachan T
A clinical, genetic and audiological study of patients and families with unilateral vestibular schwannomas. I. Clinical features of neurofibromatosis in patients with unilateral vestibular schwannomas.
The Journal of laryngology and otology 1996;110(7):634-40.
-
1996: Varley J M; McGown G; Thorncroft M; Cochrane S; Morrison P; Woll P; Kelsey A M; Mitchell E L; Boyle J; Birch J M; Evans D G
A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li-Fraumeni syndrome.
Oncogene 1996;12(11):2437-42.
-
1996: Maddock I R; Moran A; Maher E R; Teare M D; Norman A; Payne S J; Whitehouse R; Dodd C; Lavin M; Hartley N; Super M; Evans D G
A genetic register for von Hippel-Lindau disease.
Journal of medical genetics 1996;33(2):120-7.
-
1996: Colley A; Donnai D; Evans D G
Neurofibromatosis/Noonan phenotype: a variable feature of type 1 neurofibromatosis.
Clinical genetics 1996;49(2):59-64.
-
1995: Varley J M; McGown G; Thorncroft M; Tricker K J; Teare M D; Santibanez-Koref M F; Martin J; Birch J M; Evans D G
An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53.
Journal of medical genetics 1995;32(12):942-5.
-
1995: McGaughran J M; Ward H B; Evans D G
WAGR syndrome and multiple exostoses in a patient with del(11)(p11.2p14.2).
Journal of medical genetics 1995;32(10):823-4.
-
1995: Evans D G; Blair V; Strachan T; Lye R H; Ramsden R T
Variation of expression of the gene for type 2 neurofibromatosis: absence of a gender effect on vestibular schwannomas, but confirmation of a preponderance of meningiomas in females.
The Journal of laryngology and otology 1995;109(9):830-5.
-
1995: Evans D G; Bourn D; Wallace A; Ramsden R T; Mitchell J D; Strachan T
Diagnostic issues in a family with late onset type 2 neurofibromatosis.
Journal of medical genetics 1995;32(6):470-4.
-
1994: Evans D G; Blair V; Greenhalgh R; Hopwood P; Howell A
The impact of genetic counselling on risk perception in women with a family history of breast cancer.
British journal of cancer 1994;70(5):934-8.
-
1994: Bourn D; Carter S A; Evans D G; Goodship J; Coakham H; Strachan T
A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals.
American journal of human genetics 1994;55(1):69-73.
-
1994: Davies D R; Norman A M; Whitehouse R W; Evans D G
Non-expression of von Hippel-Lindau phenotype in an obligate gene carrier.
Clinical genetics 1994;45(2):104-6.
-
1993: Evans D G; Guy S P; Thakker N; Armstrong J G; Dodd C; Davies D R; Babbs C; Clancy T; Warnes T; Sloan P
Non-penetrance and late appearance of polyps in families with familial adenomatous polyposis.
Gut 1993;34(10):1389-93.
-
1993: Shah S; Evans D G; Blair V; Burnell L D; Birch J M
Assessment of relative risk of second primary tumors after ovarian cancer and of the usefulness of double primary cases as a source of material for genetic studies with a cancer registry.
Cancer 1993;72(3):819-27.
-
1993: Evans D G; Ladusans E J; Rimmer S; Burnell L D; Thakker N; Farndon P A
Complications of the naevoid basal cell carcinoma syndrome: results of a population based study.
Journal of medical genetics 1993;30(6):460-4.
-
1993: Evans D G; Ramsden R; Huson S M; Harris R; Lye R; King T T
Type 2 neurofibromatosis: the need for supraregional care?
The Journal of laryngology and otology 1993;107(5):401-6.
-
1993: Teare M D; Santibáñez-Koref M F; Wallace S A; White G R; Evans D G; Burnell L D; Harris M; Howell A; Birch J M
A linkage study in seven breast cancer families.
American journal of human genetics 1993;52(4):786-8.
-
1993: Evans D G; Burnell L D; Hopwood P; Howell A
Perception of risk in women with a family history of breast cancer.
British journal of cancer 1993;67(3):612-4.
-
1993: Neary W J; Newton V E; Vidler M; Ramsden R T; Lye R H; Dutton J E; Richardson P L; Harris R; Evans D G; Strachan T
A clinical, genetic and audiological study of patients and families with bilateral acoustic neurofibromatosis.
The Journal of laryngology and otology 1993;107(1):6-11.
-
1992: Evans D G; Huson S M; Donnai D; Neary W; Blair V; Newton V; Strachan T; Harris R
A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling.
Journal of medical genetics 1992;29(12):847-52.
-
1992: Evans D G; Huson S M; Donnai D; Neary W; Blair V; Teare D; Newton V; Strachan T; Ramsden R; Harris R
A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity.
Journal of medical genetics 1992;29(12):841-6.
-
1992: Evans D G; Huson S M; Donnai D; Neary W; Blair V; Newton V; Harris R
A clinical study of type 2 neurofibromatosis.
The Quarterly journal of medicine 1992;84(304):603-18.
-
1992: Evans D G; Harris R
Heterogeneity in genetic conditions.
The Quarterly journal of medicine 1992;84(304):563-5.
-
1992: Evans D G; Ribiero G; Warrell D; Donnai D
Ovarian cancer family and prophylactic choices.
Journal of medical genetics 1992;29(6):416-8.
-
1991: Evans D G; Farndon P A; Burnell L D; Gattamaneni H R; Birch J M
The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma.
British journal of cancer 1991;64(5):959-61.
-
1991: Evans D G; Sims D G; Donnai D
Family implications of neonatal Gorlin's syndrome.
Archives of disease in childhood 1991;66(10 Spec No):1162-3.
-
1991: Evans D G; Lonsdale R N; Patton M A
Cutaneous lymphangioma and amegakaryocytic thrombocytopenia in Noonan syndrome.
Clinical genetics 1991;39(3):228-32.
-
1991: Evans D G; Birch J M; Orton C I
Brain tumours and the occurrence of severe invasive basal cell carcinoma in first degree relatives with Gorlin syndrome.
British journal of neurosurgery 1991;5(6):643-6.
Sign-in to see more
